Hepatitis C is a viral infection which, if left untreated, can lead to severe and potentially fatal liver damage. Existing treatments consist of a combination of drugs, usually ribavirin, pegylated interferon and a protease ...
Nov 5, 2013
0
0
Hepatitis C can now be effectively treated, thanks to modern drugs. However, despite having been cured, some patients can go on to develop liver cancer. Currently, biannual ultrasound screening is done to monitor for incipient ...
Jan 28, 2022
0
16
Human apolipoprotein E (apoE) promotes hepatitis B virus (HBV) infection and production, according to a study published Aug 8 in the open-access journal PLOS Pathogens by Luhua Qiao and Guangxiang (George) Luo of the University ...
Aug 8, 2019
0
0
Predicting who may go on to develop hepatocellular carcinoma (HCC) after successful treatment for chronic hepatitis C virus (HCV) infection may now be easier, thanks to the work of two independent research teams from France ...
Aug 27, 2020
0
0
More than 180 million people in the world have hepatitis C, compared with the 34 million with HIV/AIDS and the roughly 30,000 who have had Ebola. Yet very little is heard about the hepatitis C virus (HCV) in the way of awareness ...
Feb 4, 2015
0
12
What is the incidence of viral hepatitis caused by blood transfusions before and after Sweden introduced screening of blood in the early 1990s? In an article published in Eurosurveillance ahead of World Hepatitis Day on 28 ...
Jul 23, 2020
0
4
By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate ...
Aug 2, 2013
0
0
(HealthDay) -- The global prevalence of tuberculosis, hepatitis C virus infection, and HIV is high among homeless people, although significant heterogeneity is seen in prevalence estimates, according to a study published ...
Aug 20, 2012
0
0
New data released at this year's World Hepatitis Summit in Sao Paulo, Brazil (1-3 November) show that out of an estimated 2.7 million people now living with hepatitis C in the US, only just over half (55%) are aware, contributing ...
Nov 1, 2017
0
1
Use of the botanical product silymarin, an extract of milk thistle that is commonly used by some patients with chronic liver disease, did not provide greater benefit than placebo for patients with treatment-resistant chronic ...
Jul 17, 2012
0
0
